dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:19:42Z
dc.date.accessioned2022-10-05T17:38:25Z
dc.date.available2014-05-27T11:19:42Z
dc.date.available2022-10-05T17:38:25Z
dc.date.created2014-05-27T11:19:42Z
dc.date.issued1999-01-01
dc.identifierRevista Brasileira de Oftalmologia, v. 58, n. 1, p. 27-31, 1999.
dc.identifier0034-7280
dc.identifierhttp://hdl.handle.net/11449/65703
dc.identifier2-s2.0-0032982091
dc.identifier9420249100835492
dc.identifier5988776856320701
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3915597
dc.description.abstractThe aim of this study was evaluate the effectiveness of the sodium diclophenac on the mydriasis induced by drugs and on the tearing, blepharospasm and photophobia in normal individuals that received mydriatic or cycloplegic eyedrops. We observed that there was not increase of the pupil diameter with the use of the diclophenac (f = 0,52). The photophobia symptom was mainly present in the patients with dark iris and that received the cycloplegic drops (p < 0,01). The authors concluded that there is not benefit in the use of the sodium dyclophenac eyedrops for the mydriasis increase or the decrease of the ocular symptoms in routine ophthalmologic examination.
dc.languagepor
dc.relationRevista Brasileira de Oftalmologia
dc.relation0,147
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectMydriasis
dc.subjectNon hormonal anti-inflammatory eyedrops
dc.subjectPhotophobia
dc.subjectSodium dyclophenac
dc.subjectdiclofenac
dc.subjectaccommodation paralysis
dc.subjectblepharospasm
dc.subjectdrug effect
dc.subjectfemale
dc.subjecthuman
dc.subjectlacrimation
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmydriasis
dc.subjectphotophobia
dc.subjectpupil
dc.titleAvaliacao do efeito do diclofenaco de sodio topico sobre a midriase e sintomas oculares apos dilatacao pupilar
dc.typeArtigo


Este ítem pertenece a la siguiente institución